Case Report
J Rheum Dis 2015; 22(3): 186-189
Published online June 30, 2015
© Korean College of Rheumatology
A Case of Varicelliform Zoster in a Patient Treated with Etanercept for Ankylosing Spondylitis
Correspondence to : Nak-Hyun Kim
Tumor necrosis factor-α (TNF-α) inhibitors are increasingly used in treatment of inflammatory disorders because of their im-munomodulatory efficacy. Increased risk of infection is an adverse effect of anti-TNF-α therapy. The incidence rate and severity of herpes zoster is significantly higher in patients on anti-TNF-α therapy than in the general population. The clinical pre-sentation of varicella zoster virus infection is also often atypical in these patients. We experienced a patient who presented with a disseminated varicelliform rash while on etanercept therapy for ankylosing spondylitis. (J Rheum Dis 2015;22:186-189)
Keywords Herpes zoster, TNFR-Fc fusion protein, Ankylosing spondylitis
PDF
Standard view
Export citation
Share Article
Case Report
J Rheum Dis 2015; 22(3): 186-189
Published online June 30, 2015
Copyright © Korean College of Rheumatology.
A Case of Varicelliform Zoster in a Patient Treated with Etanercept for Ankylosing Spondylitis
Sun Hee Na, Eun Young Nam, Pyoeng Gyun Choe, Wan Beom Park, Nam Joong Kim, Myoung-don Oh, Eun Young Lee, Nak-Hyun Kim
Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea
Correspondence to:Nak-Hyun Kim
Abstract
Tumor necrosis factor-α (TNF-α) inhibitors are increasingly used in treatment of inflammatory disorders because of their im-munomodulatory efficacy. Increased risk of infection is an adverse effect of anti-TNF-α therapy. The incidence rate and severity of herpes zoster is significantly higher in patients on anti-TNF-α therapy than in the general population. The clinical pre-sentation of varicella zoster virus infection is also often atypical in these patients. We experienced a patient who presented with a disseminated varicelliform rash while on etanercept therapy for ankylosing spondylitis. (J Rheum Dis 2015;22:186-189)
Keywords: Herpes zoster, TNFR-Fc fusion protein, Ankylosing spondylitis
Article Tools
Stats or Metrics
Share this article on
Related articles in JRD
-
Factors associated with anti-drug antibody production in ankylosing spondylitis patients treated with the infliximab biosimilar CT-P13
Yongbum Kim, M.D., Nayeon Choi, M.S., Ji-Hui Shin, M.S., Sungsin Jo, Ph.D., Bora Nam, M.D., Ph.D., Tae-Hwan Kim, M.D., Ph.D.
J Rheum Dis -0001; (): -
Osteopoikilosis in a young ankylosing spondylitis patient
Vitaly Omelchenko, M.D., Elena Letyagina, M.D., Maxim Korolev, M.D.
J Rheum Dis 2024; 31(4): 253-256 -
Machine learning models with time-series clinical features to predict radiographic progression in patients with ankylosing spondylitis
Bon San Koo, M.D., Ph.D., Miso Jang, M.D., Ph.D., Ji Seon Oh, M.D., Ph.D., Keewon Shin, Ph.D., Seunghun Lee, M.D., Ph.D., Kyung Bin Joo, M.D., Ph.D., Namkug Kim, Ph.D., Tae-Hwan Kim, M.D., Ph.D.
J Rheum Dis 2024; 31(2): 97-107
